For the same period, IHH revenue increased by 27% to RM5.8 billion on higher revenue intensity across all markets as more patients were seen.
The company’s net operating income, which reflects its core performance, was up by 17% y-o-y to RM368.9 million in 3QFY2023.
On Aug 29, IHH declared an interim cash dividend of 3.5 sen per share that was paid on Oct 27.
The company says it is confident of its organic growth trajectory and will continue to manage costs efficiently by expanding bed capacity, driving inpatient volume growth, upgrading facilities and equipment to provide better patient care and cater to demand and enhance revenue intensity
See also: Keppel Pacific Oak US REIT’s 1QFY2025 distributable income falls by 19.3% y-o-y to US$9.6 mil
Over the next five years, IHH is planning on increasing its bed capacity by some 33%, adding 4,000 new beds across Malaysia, India, Hong Kong, Turkey and Europe.
Overall, IHH expects continued revenue growth and double-digit return on equity (ROE), while maintaining prudent capital management and mitigating inflationary and interest rates pressures.
Shares in IHH closed 1 cent or 0.6% up on Nov 30.
